Own the gold standard ✨ in financial data & analytics

Subscribe for $2
Overview
Profile
Cann Group - Stock

Cann Group Stock

CAN.AX
AU000000CAN2
A2DSUQ

Price

0.03
Today +/-
+0
Today %
+0 %
P

Cann Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Cann Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Cann Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Cann Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Cann Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Cann Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Cann Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Cann Group’s growth potential.

Cann Group Revenue, EBIT and net profit per share

DateCann Group RevenueCann Group EBITCann Group Net Income
2025e504.78 M undefined0 undefined0 undefined
2024e201.57 M undefined0 undefined0 undefined
202313.78 M undefined-30.63 M undefined-33.79 M undefined
20226.41 M undefined-24.55 M undefined-26.47 M undefined
20214.33 M undefined-23.46 M undefined-25.1 M undefined
2020910,580 undefined-15.44 M undefined-16.94 M undefined
20192.35 M undefined-11.91 M undefined-10.93 M undefined
2018560,000 undefined-5.77 M undefined-4.73 M undefined
20170 undefined-2.6 M undefined-2.59 M undefined
20160 undefined-1.45 M undefined-1.46 M undefined
20150 undefined0 undefined0 undefined

Cann Group Stock Ratios

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2015201620172018201920202021202220232024e2025e
0000204613201504
-------50.00116.671,446.15150.75
------200.00183.33153.85--
0002008112000
0-1-2-5-11-15-23-24-3000
-----550.00--575.00-400.00-230.77--
0-1-2-4-10-16-25-26-3300
--100.00100.00150.0060.0056.254.0026.92--
0108.35108.35125.28139.69143.33259.46337.79372.2500
- - - - - - - - - - -
Details

Keystats

ⓘ

Revenue and Growth

The Cann Group Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Cann Group is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Cann Group provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Cann Group's financial health and stability.

Assets

Cann Group's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Cann Group must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Cann Group after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Cann Group's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (k)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201520162017201820192020202120222023
000000-25-26-33
0000002411
000000000
00001,0000000
000000630
000000000
000000000
0-1-2-3-7-17-20-20-22
000-5-25-34-16-45-3
00-3-323-34-17-450
00-3-27280003
000000000
0215770704613
00000041177
02157407396421
----3.00---1.00--
000000000
00733-12-62-19-21-23
-0.44-1.63-2.68-9.36-32.8-51.98-37.1-65.6-25.94
000000000

Cann Group stock margins

The Cann Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cann Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cann Group.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Cann Group's sales revenue. A higher gross margin percentage indicates that the Cann Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Cann Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Cann Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Cann Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Cann Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Cann Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Cann Group Margin History

Cann Group Gross marginCann Group Profit marginCann Group EBIT marginCann Group Profit margin
2025e149.74 %0 %0 %
2024e149.74 %0 %0 %
2023149.74 %-222.31 %-245.26 %
2022175.32 %-383 %-412.85 %
2021196.63 %-541.21 %-579.21 %
2020149.74 %-1,695.85 %-1,860.07 %
2019149.74 %-507.26 %-465.41 %
2018410.2 %-1,029.59 %-843.9 %
2017149.74 %0 %0 %
2016149.74 %0 %0 %
2015149.74 %0 %0 %

Cann Group Stock Sales Revenue, EBIT, Earnings per Share

The Cann Group earnings per share therefore indicates how much revenue Cann Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Cann Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Cann Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Cann Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Cann Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Cann Group Revenue, EBIT and net profit per share

DateCann Group Sales per ShareCann Group EBIT per shareCann Group Earnings per Share
2025e1.13 undefined0 undefined0 undefined
2024e0.45 undefined0 undefined0 undefined
20230.04 undefined-0.08 undefined-0.09 undefined
20220.02 undefined-0.07 undefined-0.08 undefined
20210.02 undefined-0.09 undefined-0.1 undefined
20200.01 undefined-0.11 undefined-0.12 undefined
20190.02 undefined-0.09 undefined-0.08 undefined
20180 undefined-0.05 undefined-0.04 undefined
20170 undefined-0.02 undefined-0.02 undefined
20160 undefined-0.01 undefined-0.01 undefined
20150 undefined0 undefined0 undefined

Cann Group business model

Cann Group Ltd is an Australian company specializing in the production and marketing of medical cannabis. The company was founded in 2013 and is headquartered in Melbourne. The company's history began with the founding of an independent consulting firm called AusCann Group Holdings Ltd in 2014. This firm was created to inform Australian and international investors about the opportunities and possibilities in the Australian cannabis market. In 2016, a cooperation agreement was signed between AusCann and Cann Group Ltd to advance the cultivation and production of medical cannabis products in Australia. Since then, Cann Group has continuously invested in the development and growth of the Australian medical cannabis market. The company has obtained a Good Manufacturing Practices (GMP) compliance license to ensure that all products meet the highest quality and safety standards. This includes collaborating with research institutions and state health authorities to investigate the efficacy and safety of medications. Cann Group's various business areas include the production of medical cannabis, research, product development, and marketing. The company operates a cannabis cultivation facility in Cochranes Hill, Victoria, covering an area of 20 hectares. The cultivation of cannabis is carried out under controlled conditions to ensure that all products are of the highest quality and purity. The cultivated cannabis is then used to manufacture medical products such as oils, tinctures, capsules, and sprays. Cann Group also collaborates closely with research institutions and academic institutions to study the safety and efficacy of medical cannabis. The company has partnerships with the University of Melbourne, Queensland University of Technology, and Swinburne University of Technology for research on the mechanisms of cannabis, application research, and studies on the clinical efficacy of cannabis. The business model of Cann Group is based on the sale of medical cannabis products to pharmacies and medical facilities in Australia and worldwide. The company, through its license, is one of the few companies capable of producing and exporting medical cannabis for the Australian market. In addition to exporting cannabis products to Germany, New Zealand, the UK, and other countries, the sale of cannabis products to the Australian market is the largest market for Cann Group. The company offers a variety of medical cannabis products specifically developed for various medical conditions. These include products for anxiety, nausea and vomiting, pain, seizures, and many other diseases. There are also products for palliative care, which help alleviate pain and suffering in the final stages. Overall, Cann Group Ltd has played a pioneering role in the development of the Australian medical cannabis market in recent years. The company specializes in the production of medical cannabis products that meet the highest quality standards and strict regulatory requirements. The company is committed to improving the therapeutic approach to diseases and enhancing the quality of life for patients. Cann Group is one of the most popular companies on Eulerpool.com.

Cann Group SWOT Analysis

Strengths

  • Strong market position as a leading cannabis producer and supplier
  • Competitive advantage in terms of scale and production capacity
  • Well-established distribution network and customer base
  • Strong brand recognition and reputation in the industry

Weaknesses

  • Reliance on external factors such as government regulations and policies
  • Vulnerability to fluctuations in cannabis prices and demand
  • Potential for increased competition in the market
  • Limited product diversification beyond cannabis-related products

Opportunities

  • Growing acceptance and legalization of cannabis globally
  • Expansion into international markets with relaxed regulations
  • Potential partnerships or collaborations with established pharmaceutical companies
  • Innovation and development of new cannabis-based products

Threats

  • Changing regulatory landscape and potential stricter regulations
  • Risk of product quality and safety concerns affecting consumer trust
  • Economic downturn impacting consumer spending on cannabis products
  • Competition from both existing and new players in the cannabis industry

Cann Group valuation based on historical P/E ratio, EBIT, and P/S ratio.

Cann Group shares outstanding

The number of shares was Cann Group in 2023 — This indicates how many shares 372.252 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Cann Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Cann Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Cann Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Cann Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Cann Group.

Cann Group Stock Shareholders

%
Name
Stocks
Change
Date
2.57 % Jacobsen (Philip)11,478,9432,432,1528/16/2023
1.96 % McCallum (Allan Donald)8,716,4771,743,2968/16/2023
1.32 % Flag Capital Pty. Ltd.5,876,453-122,0678/16/2023
1.12 % Hoeksema (Leendert)5,000,0003,740,0008/16/2023
0.97 % Supernova Fund Pty. Ltd.4,341,363136,3638/16/2023
0.81 % Rathbone (Douglas John)3,596,185165,5158/1/2023
0.79 % Page (Christopher John)3,500,0001,200,0008/16/2023
0.79 % Prue (Ryan)3,500,000180,0008/16/2023
0.70 % Hu (Shengyan)3,132,2241,132,2248/16/2023
0.57 % Anderson (Michael)2,524,620974,6208/16/2023
1
2
3

Cann Group stock: Frequently Asked Questions

What values and corporate philosophy does Cann Group represent?

Cann Group Ltd, a leading Australian medicinal cannabis company, embodies a strong set of values and corporate philosophy. The company is committed to producing high-quality medical cannabis products to improve the lives of patients. Cann Group values innovation and sustainability, constantly seeking new ways to enhance their cultivation and manufacturing processes. With a focus on research and development, they aim to continually expand their product offerings and provide effective and safe treatments. Cann Group Ltd prides itself on its dedication to investors, transparency, and regulatory compliance, ensuring a trustworthy and reliable approach to business.

In which countries and regions is Cann Group primarily present?

Cann Group Ltd is primarily present in Australia.

What significant milestones has the company Cann Group achieved?

Cann Group Ltd has achieved several significant milestones in its operations. Firstly, the company became the first Australian business to obtain a license to cultivate medicinal cannabis for research purposes in 2017. This achievement positioned Cann Group Ltd as a pioneer in the country's emerging medicinal cannabis industry. Additionally, the company successfully completed its first commercial cannabis harvest in 2018, marking another important milestone. Furthermore, Cann Group Ltd obtained its crucial Manufacture License in 2019, allowing the company to produce and distribute medicinal cannabis products in Australia. These milestones highlight Cann Group Ltd's commitment to advancing the availability and quality of medicinal cannabis within the country's market.

What is the history and background of the company Cann Group?

Cann Group Ltd is an Australian company that specializes in cultivating and producing medical cannabis. Established in 2014, Cann Group was the first to be granted a license to cultivate and research cannabis for medicinal purposes in Australia. With a strong commitment to quality and compliance, the company has built state-of-the-art facilities and established strategic partnerships to expand its operations. Cann Group is dedicated to providing safe and effective cannabis-based products to improve patient outcomes and is at the forefront of the rapidly growing medicinal cannabis industry in Australia.

Who are the main competitors of Cann Group in the market?

The main competitors of Cann Group Ltd in the market include other companies involved in the production and distribution of medical cannabis and cannabis-related products. Some significant competitors of Cann Group Ltd may include AusCann Group Holdings Ltd, Althea Group Holdings Ltd, and Little Green Pharma Ltd. These companies operate in the same industry and focus on the cultivation, manufacturing, and sale of medical cannabis products. Cann Group Ltd competes with these companies to gain market share, secure partnerships, and expand their customer base in the rapidly growing cannabis industry.

In which industries is Cann Group primarily active?

Cann Group Ltd is primarily active in the cannabis industry.

What is the business model of Cann Group?

Cann Group Ltd is an Australian company that operates in the medicinal cannabis industry. Its business model revolves around cultivation, manufacturing, and distribution of pharmaceutical-grade cannabis products and providing services to the medicinal cannabis sector. With a focus on research and development, Cann Group aims to support healthcare professionals and patients by developing high-quality therapeutic products derived from cannabis plants. The company's expertise lies in the production of standardized cannabis cultivars, extraction, and development of new formulations to meet the evolving needs of the medical industry. Cann Group Ltd strives to establish itself as a leading player in the medicinal cannabis market.

What is the P/E ratio of Cann Group 2024?

The Cann Group P/E ratio is 0.

What is the P/S ratio of Cann Group 2024?

The Cann Group P/S ratio is 0.05.

What is the AlleAktien quality score of Cann Group?

The AlleAktien quality score for Cann Group is 4/10.

What is the revenue of Cann Group 2024?

The expected Cann Group revenue is 201.57 M AUD.

How high is the profit of Cann Group 2024?

The profit cannot currently be calculated for Cann Group.

What is the business model of Cann Group

Cann Group Ltd is an Australian company specializing in the medical cannabis market. Its business model involves producing, developing, and distributing cannabis for medical use. The company serves various segments, such as the market for human medical products, the veterinary sector, and the recreational and wellness sector. The company is well positioned to benefit from the growing demand for medical cannabis, CBD products for pets, and recreational products.

What is the Cann Group dividend?

Cann Group pays a dividend of 0 AUD distributed over payouts per year.

How often does Cann Group pay dividends?

The dividend cannot currently be calculated for Cann Group or the company does not pay out a dividend.

What is the Cann Group ISIN?

The ISIN of Cann Group is AU000000CAN2.

What is the Cann Group WKN?

The WKN of Cann Group is A2DSUQ.

What is the Cann Group ticker?

The ticker of Cann Group is CAN.AX.

How much dividend does Cann Group pay?

Over the past 12 months, Cann Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cann Group is expected to pay a dividend of 0 AUD.

What is the dividend yield of Cann Group?

The current dividend yield of Cann Group is .

When does Cann Group pay dividends?

Cann Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cann Group?

Cann Group paid dividends every year for the past 0 years.

What is the dividend of Cann Group?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cann Group located?

Cann Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cann Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cann Group from 7/4/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 7/4/2024.

When did Cann Group pay the last dividend?

The last dividend was paid out on 7/4/2024.

What was the dividend of Cann Group in the year 2023?

In the year 2023, Cann Group distributed 0 AUD as dividends.

In which currency does Cann Group pay out the dividend?

The dividends of Cann Group are distributed in AUD.

Other fundamentals and analyses of Cann Group in the deep dive.

Our stock analysis for Cann Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cann Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.